NEVIRAPINE
- Product NDC
- 65862-932
- 11-digit product format
- 658620932
- Labeler code
- 65862
- Product ID
- 65862-932_bbc31c76-0d52-4d56-82be-0e501f57ab72
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NEVIRAPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA208616
- Marketing category
- ANDA
- Marketing start
- 2016-11-23
- Marketing end
- 0000-00-00
- Substance
- NEVIRAPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-932-05 | 65862093205 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-05) | 2016-11-23 | 0000-00-00 | No | No | Current |
| 65862-932-90 | 65862093290 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-90) | 2016-11-23 | 0000-00-00 | No | No | Current |
| 65862-932-99 | 65862093299 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-99) | 2016-11-23 | 0000-00-00 | No | No | Current |